These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32829523)

  • 1. Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy.
    Hönger G; Niemann M; Schawalder L; Jones J; van Heck MR; van de Pasch LAL; Vendelbosch S; Rozemuller EH; Hösli I; Blümel S; Schaub S
    HLA; 2020 Nov; 96(5):589-600. PubMed ID: 32829523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
    Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
    Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.
    Kramer CSM; Bezstarosti S; Franke-van Dijk MEI; Vergunst M; Roelen DL; Uyar-Mercankaya M; Voogt-Bakker KH; Heidt S
    HLA; 2024 Jan; 103(1):e15345. PubMed ID: 38239050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.
    Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S
    Front Immunol; 2021; 12():800946. PubMed ID: 35154076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.
    Schawalder L; Hönger G; Kleiser M; van Heck MR; van de Pasch LAL; Vendelbosch S; Rozemuller EH; Schaub S
    HLA; 2021 Jan; 97(1):30-43. PubMed ID: 33068062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
    Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
    Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.
    Bezstarosti S; Kramer CSM; Claas FHJ; de Fijter JW; Reinders MEJ; Heidt S
    Hum Immunol; 2022 Mar; 83(3):256-263. PubMed ID: 34963506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia.
    Stefańska K; Kurkowiak M; Piekarska K; Chruściel E; Zamkowska D; Jassem-Bobowicz J; Adamski P; Świątkowska-Stodulska R; Abacjew-Chmyłko A; Leszczyńska K; Zieliński M; Preis K; Zielińska H; Tymoniuk B; Trzonkowski P; Marek-Trzonkowska NM
    Front Immunol; 2023; 14():1272021. PubMed ID: 38022600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
    Marrari M; Duquesnoy RJ
    Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Anti-HLA Antibody Strength Underestimation in Single Antigen Bead Assay for Shared Eplets.
    Claisse G; Devriese M; Lion J; Maillard N; Caillat-Zucman S; Mooney N; Taupin JL
    Transplantation; 2022 Dec; 106(12):2456-2461. PubMed ID: 35849751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HLA-A, -B, -DR, -DQB1 and -DQA1 antibodies reactive epitope determination with HLAMatchmaker in multipare awaiting list for heart transplant.
    Resse M; Paolillo R; Casamassimi A; Cavalca F; Fiorito C; Maiello C; Napoli C
    Hum Immunol; 2013 Aug; 74(8):937-41. PubMed ID: 23628396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA graph, a free and ready-to-use bioinformatics tool to explore anti-HLA eplets reactivity pattern.
    Usureau C; Jacob V; Dubois V; Masson D; Jollet I; Desoutter J; Taupin JL; Guillaume N
    HLA; 2022 Sep; 100(3):244-253. PubMed ID: 35672253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second update of the International Registry of HLA Epitopes. I. The HLA-ABC Epitope Database.
    Duquesnoy RJ; Marrari M; Marroquim MS; Borges AG; da Mata Sousa LCD; Socorro A; do Monte SJH
    Hum Immunol; 2019 Feb; 80(2):103-106. PubMed ID: 30458204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?
    Duquesnoy RJ
    Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation.
    Otten HG; Calis JJ; Keşmir C; van Zuilen AD; Spierings E
    Hum Immunol; 2013 Mar; 74(3):290-6. PubMed ID: 23232063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets.
    Marrari M; Mostecki J; Mulder A; Claas F; Balazs I; Duquesnoy RJ
    Transplantation; 2010 Dec; 90(12):1468-72. PubMed ID: 21063243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of the ElliPro epitope predictor program in defining the repertoire of HLA-ABC eplets.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2017; 78(7-8):481-488. PubMed ID: 28336309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.